Sarepta Therapeutics Inc (SRPT)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
The data provided for Sarepta Therapeutics Inc indicates that the Days of Sales Outstanding (DSO) for the years ending December 31, 2020, 2021, 2022, 2023, and 2024 are "— days" across the board. This suggests that there is no specific information available regarding the exact number of days it takes for the company to collect its accounts receivable on average during these years.
As a financial analyst, it is essential to note that a lower DSO value typically indicates that a company is efficient in collecting payments from its customers, leading to better liquidity and cash flow management. On the other hand, a higher DSO could imply potential issues with credit policies, collections, or customer payment delays, which might impact the company's working capital and overall financial health.
Without the specific DSO values provided in the data, further analysis and comparison with industry averages or historical data for Sarepta Therapeutics Inc would be necessary to assess the company's efficiency in managing its accounts receivable and its overall financial performance.
Peer comparison
Dec 31, 2024